FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032959558> ?p ?o ?g. }

• W2032959558 endingPage "3808" @default.
• W2032959558 startingPage "3801" @default.
• W2032959558 abstract "ABSTRACT Atazanavir (ATV) is a new azapeptide protease inhibitor recently approved and currently used at a fixed dose of either 300 mg once per day (q.d.) in combination with 100 mg ritonavir (RTV) or 400 mg q.d. without boosting. ATV is highly bound to plasma proteins and extensively metabolized by CYP3A4. Since ATV plasma levels are highly variable and seem to be correlated with both viral response and toxicity, dosage individualization based on plasma concentration monitoring might be indicated. This study aimed to assess the ATV pharmacokinetic profile in a target population of HIV patients, to characterize interpatient and intrapatient variability, and to identify covariates that might influence ATV disposition. A population analysis was performed with NONMEM with 574 plasma samples from a cohort of 214 randomly selected patients receiving ATV. A total of 346 randomly collected ATV plasma levels and 19 full concentration-time profiles at steady state were available. The pharmacokinetic parameter estimates were an oral clearance (CL) of 12.9 liters/h (coefficient of variation [CV], 26%), a volume of distribution of 88.3 liters (CV, 29%), an absorption rate constant of 0.405 h −1 (CV, 122%), and a lag time of 0.88 h. A relative bioavailability value was introduced to account for undercompliance due to infrequent follow-ups (0.81; CV, 45%). Among the covariates tested, only RTV significantly reduced CL by 46%, thereby increasing the ATV elimination half-life from 4.6 h to 8.8 h. The pharmacokinetic parameters of ATV were adequately described by a one-compartment population model. The concomitant use of RTV improved the pharmacokinetic profile. However, the remaining high interpatient variability suggests the possibility of an impact of unmeasured covariates, such as genetic traits or environmental influences. This population pharmacokinetic model, together with therapeutic drug monitoring and Bayesian dosage adaptation, can be helpful in the selection and adaptation of ATV doses." @default.
• W2032959558 created "2016-06-24" @default.
• W2032959558 creator A5011217027 @default.
• W2032959558 creator A5014858344 @default.
• W2032959558 creator A5037441803 @default.
• W2032959558 creator A5066398751 @default.
• W2032959558 creator A5072524565 @default.
• W2032959558 creator A5072851099 @default.
• W2032959558 creator A5091531260 @default.
• W2032959558 date "2006-11-01" @default.
• W2032959558 modified "2023-09-27" @default.
• W2032959558 title "Population Pharmacokinetics of Atazanavir in Patients with Human Immunodeficiency Virus Infection" @default.
• W2032959558 cites W1987126955 @default.
• W2032959558 cites W1991872551 @default.
• W2032959558 cites W2001169776 @default.
• W2032959558 cites W2003143162 @default.
• W2032959558 cites W2028731404 @default.
• W2032959558 cites W2042416176 @default.
• W2032959558 cites W2051212479 @default.
• W2032959558 cites W2066996342 @default.
• W2032959558 cites W2097656057 @default.
• W2032959558 cites W2100414335 @default.
• W2032959558 cites W2116734592 @default.
• W2032959558 cites W2117312836 @default.
• W2032959558 cites W2118861418 @default.
• W2032959558 cites W2123841216 @default.
• W2032959558 cites W2134741406 @default.
• W2032959558 cites W2142635246 @default.
• W2032959558 cites W2162800322 @default.
• W2032959558 cites W2417370313 @default.
• W2032959558 cites W3191746761 @default.
• W2032959558 cites W4250028878 @default.
• W2032959558 cites W97420631 @default.
• W2032959558 doi "https://doi.org/10.1128/aac.00098-06" @default.
• W2032959558 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1635184" @default.
• W2032959558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16940065" @default.
• W2032959558 hasPublicationYear "2006" @default.
• W2032959558 type Work @default.
• W2032959558 sameAs 2032959558 @default.
• W2032959558 citedByCount "83" @default.
• W2032959558 countsByYear W20329595582012 @default.
• W2032959558 countsByYear W20329595582013 @default.
• W2032959558 countsByYear W20329595582014 @default.
• W2032959558 countsByYear W20329595582015 @default.
• W2032959558 countsByYear W20329595582016 @default.
• W2032959558 countsByYear W20329595582017 @default.
• W2032959558 countsByYear W20329595582018 @default.
• W2032959558 countsByYear W20329595582019 @default.
• W2032959558 countsByYear W20329595582020 @default.
• W2032959558 countsByYear W20329595582021 @default.
• W2032959558 countsByYear W20329595582022 @default.
• W2032959558 crossrefType "journal-article" @default.
• W2032959558 hasAuthorship W2032959558A5011217027 @default.
• W2032959558 hasAuthorship W2032959558A5014858344 @default.
• W2032959558 hasAuthorship W2032959558A5037441803 @default.
• W2032959558 hasAuthorship W2032959558A5066398751 @default.
• W2032959558 hasAuthorship W2032959558A5072524565 @default.
• W2032959558 hasAuthorship W2032959558A5072851099 @default.
• W2032959558 hasAuthorship W2032959558A5091531260 @default.
• W2032959558 hasBestOaLocation W20329595581 @default.
• W2032959558 hasConcept C112705442 @default.
• W2032959558 hasConcept C139254425 @default.
• W2032959558 hasConcept C142462285 @default.
• W2032959558 hasConcept C181389837 @default.
• W2032959558 hasConcept C203014093 @default.
• W2032959558 hasConcept C2776239304 @default.
• W2032959558 hasConcept C2777182164 @default.
• W2032959558 hasConcept C2778414717 @default.
• W2032959558 hasConcept C2779298103 @default.
• W2032959558 hasConcept C2908647359 @default.
• W2032959558 hasConcept C2993143319 @default.
• W2032959558 hasConcept C3013748606 @default.
• W2032959558 hasConcept C71924100 @default.
• W2032959558 hasConcept C98274493 @default.
• W2032959558 hasConcept C99454951 @default.
• W2032959558 hasConceptScore W2032959558C112705442 @default.
• W2032959558 hasConceptScore W2032959558C139254425 @default.
• W2032959558 hasConceptScore W2032959558C142462285 @default.
• W2032959558 hasConceptScore W2032959558C181389837 @default.
• W2032959558 hasConceptScore W2032959558C203014093 @default.
• W2032959558 hasConceptScore W2032959558C2776239304 @default.
• W2032959558 hasConceptScore W2032959558C2777182164 @default.
• W2032959558 hasConceptScore W2032959558C2778414717 @default.
• W2032959558 hasConceptScore W2032959558C2779298103 @default.
• W2032959558 hasConceptScore W2032959558C2908647359 @default.
• W2032959558 hasConceptScore W2032959558C2993143319 @default.
• W2032959558 hasConceptScore W2032959558C3013748606 @default.
• W2032959558 hasConceptScore W2032959558C71924100 @default.
• W2032959558 hasConceptScore W2032959558C98274493 @default.
• W2032959558 hasConceptScore W2032959558C99454951 @default.
• W2032959558 hasIssue "11" @default.
• W2032959558 hasLocation W20329595581 @default.
• W2032959558 hasLocation W20329595582 @default.
• W2032959558 hasLocation W20329595583 @default.
• W2032959558 hasLocation W20329595584 @default.
• W2032959558 hasOpenAccess W2032959558 @default.
• W2032959558 hasPrimaryLocation W20329595581 @default.
• W2032959558 hasRelatedWork W1901877366 @default.

• next